Quarter Period Consolidated Statement Of Comprehensive Income

Carna Biosciences, Inc. - Filing #7550971

Concept 2023-01-01 to
2023-06-30
2022-01-01 to
2022-06-30
Quarter period consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-885,608,000 JPY
-359,120,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-340,000 JPY
-1,241,000 JPY
Deferred gains or losses on hedges
-615,000 JPY
87,600,000 JPY
Foreign currency translation adjustment
25,174,000 JPY
36,662,000 JPY
Other comprehensive income
24,217,000 JPY
123,021,000 JPY
Comprehensive income
-861,390,000 JPY
-236,098,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-861,390,000 JPY
-236,098,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.